Healthcare - Biotechnology - NASDAQ - US
$ 0.035
-44.6 %
$ 119 K
Market Cap
0.01
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
81.37%
EBIT
Estimate
64.90%
Net Income
Estimate
39.26%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
TRACON Pharmaceuticals, Inc.
TCON has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart TCON
EBIT FORECAST
EBIT Forecast Chart TCON
NET INCOME FORECAST
Net Income Chart TCON